Bright Green (Bright Green) Debt-to-Asset : 0.11 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bright Green Debt-to-Asset?

Bright Green's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.65 Mil. Bright Green's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.20 Mil. Bright Green's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $17.40 Mil. Bright Green's debt to asset for the quarter that ended in Dec. 2023 was 0.11.

Bright Green Debt-to-Asset Historical Data

The historical data trend for Bright Green's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bright Green Debt-to-Asset Chart

Bright Green Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.05

0.25

0.11

Bright Green Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial								0.25	0.21	0.21	0.07	0.11

Competitive Comparison of Bright Green's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Bright Green's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bright Green's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bright Green's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bright Green's Debt-to-Asset falls into.

Bright Green Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bright Green's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.65	+	0.202)	/	17.403
	=	0.11

Bright Green's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.65	+	0.202)	/	17.403
	=	0.11

Bright Green (NAS:BGXX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Bright Green Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bright Green's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Green (Bright Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (NAS:BGXX) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1033 George Hanosh Boulevard, Grants, NM, USA, 87020

Website

https://www.brightgreen.us

Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).

Executives

Gurvinder Singh	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Saleem Elmasri	officer: Chief Financial Officer	450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Seamus Mcauley	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson	director, officer: Chief Executive Officer	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc.	10 percent owner	3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1